All News

A test that uses gold nanoparticles to detect early-stage prostate cancer costs less than $1, returns results in minutes and is more accurate than standard PSA screening, pilot studies show.

Accountable care organizations can leverage health information technology to improve patient safety without creating alert fatigue among providers, according to a study in the Journal of Managed Care & Specialty Pharmacy.

Authors say until now, no one has reported on the discrepancies that arise when applying pediatric vs adult guidelines on young people transitioning to adulthood.

By combining, in a liposome, magnetic nanoparticles and photosensitizers that are simultaneously and remotely activated by a magnetic field and light, scientists obtained total tumor regression in mice.

The Workgroup for Electronic Data Interchange sent a letter to HHS Secretary Sylvia M. Burwell on March 31 explaining that the 1-year delay for implementation of the International Classification of Diseases, Tenth Revision may have done more harm than good.

The trial, whose results were published in the Journal of Clinical Oncology, found that circulating tumor cells and lactose dehydrogenase are ideal surrogates to predict overall survival in patients with advanced prostate cancer.

Democratic-led efforts to ban vaccine exemptions in Oregon and Washington state toppled one after the other last month. Now it's California's turn to try.

Implementing a value-based drug formulary that uses cost-effectiveness analyses after safety and efficacy decreased pharmacy costs by 3% in the first year, according to a study published in the Journal of Managed Care & Specialty Pharmacy.

One day, cancer treatment regimens might include vaccines specially tailored to each patient. In a small preliminary study published in Science, researchers report successful use of these vaccines in 3 patients.

New analysis from Avalere finds that while exchanges have succeeded in enrolling very low-income individuals, they continue to struggle to attract middle and higher income enrollees.

Shigella sonnei is a strain of bacteria that causes severe diarrhea in about half a million people in the US each year. Most of the time, it's treated effectively with an antibiotic called Cipro. But that's changing, and it's bad news.

A one-minute look at managed care news during the week of March 30, 2015, including a Supreme Court ruling regarding Medicaid reimbursement and UnitedHealth buys Catamaran.

About 36,000 people have taken advantage of a second chance to sign up for coverage under the president's healthcare law, the Obama administration said Wednesday.

What's worse: Ebola or AIDS? Measles or malnutrition? Lung cancer or low back pain? As individuals, as a nation, and as a global community, where should we focus our time and money to improve lives the most?

The Affordable Care Act enacted a number of new taxes, but one hits the small business community harder than others: the health insurance tax.

Five class-action lawsuits claim that Premera was negligent, breached its contract with customers, violated the Washington Consumer Protection Act, and failed to disclose the data breach in a timely manner.

The prevalence of major depressive disorder (MDD) grew from a rate of 6.4% in 2005 to 6.8% in 2010 with the cost of MDD to employers increasing 21.5% over the same time period, according to a new study in the Journal of Clinical Psychiatry.

Contributions from employers and workers to health savings accounts were on the decline in 2014, according to new research from the Employee Benefit Research Institute.

Although those opposing the Affordable Care Act have decried the burdensome nature of the individual mandate, a recent proposal developed by Republicans seeks to address the same problem as the ACA's mandate and would impose strong penalties on the uninsured.

Several high-profile disputes between health systems and insurers made headlines in recent months, with some of those disagreements leading to contracts expiring without a new one in place.

A 2011 switch to Medicaid managed care, which occurred during a budget crisis, has been blamed for financial challenges at rural hospitals and declining numbers of providers. Auditor Adam Edelen said the plight of Kentucky's rural hospitals is complex but must be addressed.

Researchers at Dartmouth's Norris Cotton Cancer Center designed rehabilitation intervention to help women with breast cancer find ways to accelerate recovery and engage in health-promoting activities.

Senator Robert Menendez is accused of using his position to help a Florida doctor who split vials of the eye drug Lucentis and then billed Medicare for multiple treatments.

With a focus on improving quality while maintaining the cost of care, providers and payers are evaluating various payment models that could improve patient outcomes using evidence-based treatment at lower costs to the healthcare system.

The Robert Wood Johnson Foundation's advisory committee for the Data for Health initiative released its first report with insights, concerns, and ideas from the public about how to harness data to improve health.

While supporting the FDA's standards-based regulatory efforts to explore next generation sequencing tests as diagnostic tools, the American Society of Clinical Oncology warned against misinterpretation or over-interpretation of test results.

Research published by a team of Italian scientists in the Journal of the National Institute of Cancer shows that a 13-gene panel blood test for microRNAs could be a cost-effective screening tool for lung cancer, compared with low-dose CT, which is expensive.

States that decide to carve out their pharmacy benefits from Medicaid plans have significantly higher costs, according to a report requested by America's Health Insurance Plans from The Menges Group.

With an aim to grab band-width in the shared PD-1 space, Merck has partnered with Syntax to conduct combination studies of Keytruda with Entinostat in melanoma and lung cancer patients.

Aggressive policies that target the use and promotion of off-label use are needed to prevent the use of drugs for non-approved indications with little benefit or with harmful outcomes.